Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
| Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 26.03M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 26.03M | $ -988.00K | $ -1.03M | $ 0.00 |
| Operating Income | $ -58.07M | $ -22.45M | $ -62.07M | $ -117.66M | $ -99.15M |
| EBITDA | $ -58.07M | $ -21.79M | $ -58.37M | $ -117.03M | $ -201.72M |
| Net Income | $ -55.48M | $ -15.63M | $ -59.50M | $ -116.42M | $ -205.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.34M | $ 93.71M | $ 118.65M | $ 164.65M | $ 268.02M |
| Total Assets | $ 56.08M | $ 101.28M | $ 125.89M | $ 177.01M | $ 291.39M |
| Total Debt | $ 690.00K | $ 178.00K | $ 465.00K | $ 437.88K | $ 124.52K |
| Net Debt | $ -37.66M | $ -78.05M | $ -105.54M | $ -79.93M | $ -267.90M |
| Total Liabilities | $ 14.10M | $ 9.12M | $ 24.85M | $ 16.81M | $ 18.82M |
| Stockholders' Equity | $ 41.98M | $ 92.17M | $ 101.04M | $ -463.76M | $ 272.57M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.64M | $ -24.36M | $ -48.22M | $ -103.55M | $ -93.03M |
| Operating Cash Flow | $ -51.21M | $ -23.61M | $ -47.93M | $ -99.27M | $ -85.57M |
| Investing Cash Flow | $ 9.82M | $ -3.45M | $ 75.16M | $ -83.44M | $ -5.34M |
| Financing Cash Flow | $ 1.09M | $ 227.00K | $ -246.00K | $ -91.28K | $ 206.66M |